Gyre Therapeutics, Inc. GYRE Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s total cost of revenue?
- Gyre Therapeutics, Inc. (GYRE) reported total cost of revenue of $1.23M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s total cost of revenue changed year-over-year?
- Gyre Therapeutics, Inc.'s total cost of revenue increased by 37.2% year-over-year, from $894K to $1.23M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s total cost of revenue?
- Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s total cost of revenue has grown at a 4.2% compound annual growth rate (CAGR), from $4.79M to $5.42M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.